Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant

Environmental Science and Pollution Research

Volumn 19, Issue 5, 2012, Pages 1818-1827

  Salgado, R ^a,c   Marques, R ^a,b   Noronha, J P ^a   Carvalho, G ^a,b   Oehmen, A ^a   Reis, M A M ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^c INSTITUTO POLITÉCNICO DE SETÚBAL   (Portugal)

Author keywords

Mass balance; Musks; Pharmaceutical active compounds (PhAC); Pharmaceuticals and personal care products (PPCP); UV disinfection; Wastewater treatment

Indexed keywords

DICLOFENAC; DRUG; DRUG DERIVATIVE; ETOFENAMATE; FLUFENAMIC ACID; HYDROXYZINE; IBUPROFEN; INDAPAMIDE; PERFUME;

ACTIVATED SLUDGE; ADSORPTION; ASSESSMENT METHOD; DISINFECTION; DRUG; POLLUTANT REMOVAL; ULTRAVIOLET RADIATION; WASTEWATER;

ADSORPTION; ARTICLE; ISOLATION AND PURIFICATION; MASS FRAGMENTOGRAPHY; METHODOLOGY; SEWAGE; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION; WATER POLLUTANT;

ADSORPTION; DICLOFENAC; FLUFENAMIC ACID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDROXYZINE; IBUPROFEN; INDAPAMIDE; PERFUME; PHARMACEUTICAL PREPARATIONS; SEWAGE; SOLID PHASE EXTRACTION; ULTRAVIOLET RAYS; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 84863220986     PISSN: 09441344     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11356-011-0693-z     Document Type: Article

References (40)

1. Andersen H, Siegrist H, Halling-Sørensen B, Ternes TA (2003) The fate of estrogens in municipal sewage treatment plant. Environ Sci Technol 37: 4021-4026.
2. Andersen HR, Hansen M, Ingerslev F, Kjolholt J, Stuer-Lauridsen F, Ternes T, Halling-Sorensen B (2005) Assessment of the importance of sorption for steroid estrogens removal during activated sludge treatment. Chemosphere 61: 139-146.
3. APHA, AWWA, WPCF (1995) Standard methods for the examination of water and wastewater, 19th edn. Port City Press, Baltimore.
4. Artola-Garicano E, Borkent I, Hermens JLM, Vaes WHJ (2003) Removal of two polycyclic musks in sewage treatment plants: freely dissolved and total concentrations. Environ Sci Technol 37: 3111-3116.
5. Bundschuh M, Gessner MO, Fink G, Ternes TA, Sogding C, Schulz R (2011) Ecotoxicological evaluation of wastewater ozonation based on detritus-detritivore interactions. Chemosphere 82: 355-361.
6. Carballa M, Omil F, Lema JM, Llompart M, García-Jares C, Rodríguez I, Gómez M, Ternes T (2004) Behavior of pharmaceutical, cosmetics and hormones in sewage treatment plant. Water Res 38: 2918-2926.
7. Carballa M, Omil F, Lema JM (2007) Calculation methods to perform mass balances of micropollutants in sewage treatment plants. Application to pharmaceutical and personal care products (PPCPs). Environ Sci Technol 41: 884-890.
8. Carrara C, Ptacek CJ, Robertson WD, Blowes DW, Moncur MC, Sverko E, Backus S (2008) Fate of pharmaceutical and trace organic compounds in three septic system plumes, Ontario, Canada. Environ Sci Technol 42: 2805-2811.
9. Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H (2005a) Removal of pharmaceuticals, fragrances and endocrine disrupting compounds in membrane bioreactor and conventional wastewater treatment plants. Water Res 39: 4797-4807.
10. Clara M, Kreuzinger N, Strenn B, Gans O, Kroiss H (2005b) The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 39: 97-106.
11. Clara M, Gans O, Windhofer G, Krenn U, Hartl W, Braun K, Scharf S, Scheffknecht C (2011) Occurrence of polycyclic musks in wastewater and receiving water bodies and fate during wastewater treatment. Chemosphere 82: 1116-1123.
12. De Witte B, Dewulf J, Demeestere K, van Langenhove H (2009) Ozonation and advanced oxidation by the peroxone process of ciprofloxacin in water. J Hazard Mater 161: 701-708.
13. Gagné F, Blaise C, André C (2006) Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbouw trout (Oncorhynchus mykiss) hepatocytes. Ecotox Environ Safe 64: 329-336.
14. Gobel A, Thomsen A, McArdell CS, Joss A, Giger W (2005) Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 39: 3981-3989.
15. Gupta VK, Mittal A, Jain R, Mathur M, Sikarwar S (2006) Adsorption of Safranin-T from wastewater using waste materials-activated carbon and activated rice husks. J Colloid Interface Sci 303: 80-86.
16. Gupta VK, Rastogi A, Nayak A (2010) Adsorption studies on the removal of hexavalent chromium from aqueous solution using a low cost fertilizer industry waste material. J Colloid Interface Sci 342: 135-141.
17. Hartmann J, Bartels P, Mau U, Witter M, Tumpling WV, Hofmann J, Nietzschmann E (2008) Degradation of the drug diclofenac in water by sonolysis in presence of catalysts. Chemosphere 70: 453-461.
18. Jélic A, Gros M, Ginebreda A, Cespedes-Sánchez R, Ventura F, Petrovic M, Barcelo D (2011) Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res 45: 1165-1176.
19. Joss A, Keller E, Alder AC, Gobel A, McArdell CS, Ternes T, Siegrist H (2005) Removal, of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39: 3139-3152.
20. Joss A, Zabczynski S, Gobel A, Hoffmann B, Loffler D, McArdell CS, Ternes TA, Thomsen A, Siegrist H (2006) Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 40: 1686-1696.
21. Kreuzinger N, Clara M, Strenn B, Vogel B (2004) Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater. Water Sci Technol 50(2): 221-228.
22. Méndez-Arriaga F, Torres-Palma RA, Pétriera C, Esplugas S, Gimenez S, Pulgarin C (2009) Mineralization enhancement of a recalcitrant pharmaceutical pollutant in water by advanced oxidation hybrid processes. Water Res 43: 3984-3991.
23. Mittal A, Kaur D, Mittal J (2009) Batch and bulk removal of a triarylmethane dye, Fast Green FCF, from wastewater by adsorption over waste materials. J Hazard Mater 163: 568-577.
24. Mittal A, Mittal J, Malviya A, Kaur D, Gupta VK (2010) Adsorption of hazardous dye crystal violet from wastewater by waste materials. J Colloid Interface Sci 343: 463-473.
25. Naddeo V, Meric S, Kassinos D, Belgiorno V, Guida M (2009a) Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation. Water Res 43: 4019-4027.
26. Naddeo V, Belgiorno V, Ricco D, Kassinos D (2009b) Degradation of diclofenac during sonolysis, ozonation and their simultaneous application. Ultrason Sonochem 16: 790-794.
27. Nakada N, Komori K, Suzuki Y (2005) Occurrence and fate of anti-inflammatory drugs in wastewater treatment plants in Japan. Environ Sci 12: 359-369.
28. Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H (2006) Pharmaceutical chemicals and endocrine disruptors in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res 40: 3297-3303.
29. Ort C, Lawrence MG, Rieckermann J, Joss A (2010) Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: Are your conclusions valid? A critical review. Environ Sci Technol 44: 6024-6035.
30. Oulton RL, Kohn T, Cwiertny DM (2010) Pharmaceuticals and personal care products in effluent matrices: a survey of transformation and removal during wastewater treatment and implications for wastewater management. J Environ Monit 12: 1956-1978.
31. Plósz B, Leknes H, Thomas KV (2010) Impacts of competitive inhibition, parent compound formation and partitioning behavior on the removal of antibiotics in municipal wastewater treatment. Environ Sci Technol 44: 734-742.
32. Radienovic J, Petrovic M, Barceló D (2009) Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 43: 831-841.
33. Rua Gomez PC, Puttmann W (2011) Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants. Environ Sci Pollut Res. doi: 10. 1007/s11356-011-0614-1.
34. Salgado R, Noronha JP, Oehmen A, Carvalho G, Reis MAM (2010) Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology. Water Sci Technol 62: 2862-2871.
35. Salgado R, Marques R, Noronha JP, Mexia JT, Carvalho G, Oehmen A, Reis MAM (2011) Assessing the diurnal variability of pharmaceutical and personal care products in a full-scale activated sludge plant. Environ Pollut 159: 2359-2367.
36. 3, and Fe(VI): kinetics assessment. Chemosphere 73: 1379-1386.
37. Sim W, Lee J, Lee E, Shin S, Hwang S, Oh J (2011) Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 82: 179-186.
38. Ternes TA, Herrmann N, Bonerz M, Knacker T, Siegrist H, Joss A (2004) A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Res 38: 4075-4084.
39. Xue W, Wua C, Xiao K, Huang X, Zhou H, Tsuno H, Tanaka H (2010) Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation. Water Res 44: 5999-6010.
40. Zuccato E, Castiglioni S, Fanelli R, Reitano G, Bagnati R, Chiabrando C, Pomati F, Rossetti C, Calamari D (2006) Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environ Sci Pollut Res Int 13(1): 15-21.